IBD Screen Of The Day: Keep An Eye On These Top Global Stocks Near Buy Points

By Investor’s Business Daily

Danish drugmaker Novo Nordisk is in a buy range after breaking out of a cup base and passing its 117.45 buy point. The company produces drugs to combat diabetes, hormone disorders and obesity. The FDA approved Novo Nordisk's drug Ozempic for treatment of type 2 diabetes on March 28.

…read more

Via:: Sports Headlines

      

Get 20% off hat purchases for ONLY $5! Join our LIDS Club @ lids.com.
%d bloggers like this: